Developing an mHealth Application to Improve Cancer Chemotherapy Symptom Management
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 16
- 试验地点
- 1
- 主要终点
- Patient Satisfaction and Usability of the MyChemoCare Application
研究概览
简要总结
This research project addresses critical gaps in cancer symptom management through the creation of a mobile chemotherapy symptom management application. This application will assess for the presence and severity of common chemotherapy side-effects and provide personally tailored symptom-related video and narratives to enhance self-management of cancer and treatment-related symptoms. This study will examine patient acceptance and use of this mHealth application (called MyChemoCare) in a prospective trial of cancer patients (n=60) who are receiving chemotherapy for colorectal cancer at the University of Michigan Comprehensive Cancer Center.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with colon or rectal cancer
- •Expected to live at least 6 months
- •Initiating chemotherapy for the first time in their treatment history
- •Physically and mentally able to participate
- •Able to read English
- •Willing and able to sign informed consent
排除标准
- •A treatment plan that does not include cytotoxic chemotherapy for colon or rectal cancer
- •A medical history that includes cancer with the exception of in situ cancers of the cervix and basal cell cancers of the skin
- •A current diagnosis that includes multiple cancers (this does not exclude metastatic disease)
- •Received prior cytotoxic chemotherapy for any reason
- •A diagnosed psychiatric disorder
研究组 & 干预措施
MyChemoCare
Participants will receive access to the the MyChemoCare iPad application, which allows them to track cancer and chemotherapy related symptoms daily, and suggests strategies that may help the participant deal with these symptoms. While using the application, high symptom severity scores will be reported to the participant's medical team, who may intervene to help relieve the symptom. Participants will also be contacted if they have not checked in for 48 hours to make sure they are coping well with their chemotherapy regimen.
干预措施: MyChemoCare iPad application (Device)
结局指标
主要结局
Patient Satisfaction and Usability of the MyChemoCare Application
时间窗: 8 weeks post enrollment
The investigators will use a 9-item survey developed by Dr. An to assess patients' experiences using the MyChemoCare app. This result is the mean of the the survey items (with opposite items reversed). The scale was scored from 0 = Strongly disagree to 6 = Strongly agree.
Patient Retention and Engagement With the MyChemoCare Application
时间窗: 8 weeks post-enrollment
Patient retention is defined as the number of patients who completed the 8-week study through the final evaluation. Engagement with the MyChemoCare application was measured as number of patients who checked in at least once per week of the study.
次要结局
- Symptom Burden Reduction(8 weeks post enrollment)
- Increased Mastery of Cancer and Chemotherapy Symptoms(8 weeks post enrollment)
- Physician Use of the Study Feedback Mechanism(8 weeks post-enrollment)
- Improved Quality of Life(Baseline and 8 weeks post enrollment)
研究者
Lawrence C. An
Associate Professor of Internal Medicine
University of Michigan